The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1510
ISSUE1510
December 19, 2016
Celecoxib Safety Revisited
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Celecoxib Safety Revisited
December 19, 2016 (Issue: 1510)
The results of a clinical trial (PRECISION) comparing
the cardiovascular safety of the COX-2 selective
NSAID celecoxib (Celebrex, and generics) with that
of ibuprofen and naproxen, which are nonselective,
have been described in the lay press in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.